A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OCB / oligoclonal bands

[Related PubMed/MEDLINE]
Total Number of Papers: 143
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OCB  (>> Co-occurring Abbreviation)
Long Form:   oligoclonal bands
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis. CIS, CSF, FLC, MS
2020 Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing. CSF, FLC-k
2020 Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry. IPND, NMOAG, NMOSD, TM
2019 A unique case of multiphasic ADEM or what else? ADEM, MDEM, MS, NMOSD, RDEM
2019 Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis. CSF, FLC, Ig, MS
2019 Bad Tests Die Slowly: The Myelin Basic Protein Example. MBP, MS
2019 Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis. AIE, CNS, CSF, GAD
2019 Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study. RRMS
2019 Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China. MRI, MS
10  2019 Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern India. CIS, CSF, MRI, MS
11  2019 CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort. FLC, IgG, MS
12  2019 Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study. CC, CSF1R, HDLS, MRI, MS, PPMS, WMLs
13  2019 Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis. CIS, CNS, CSF, FLC, FLCIF, MS, QFLC, ROC
14  2019 High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. CDMS, CIS, CSF, ELISA, HR, MRI, MS, NfL, SD
15  2019 Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study. CSF, GTS, HEK, MRI, rat
16  2019 Intrathecal immunoglobulin synthesis: The potential value of an adjunct test. CSF, KFLC, LR, MS
17  2019 Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis. aHSCT, CSF, IgG, NFL
18  2019 Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients. CSF, MS
19  2019 Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study. CI, CIS, CSF, KFLC, LFLC, MS
20  2019 Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment options. CSF, MS
21  2019 Nonlesional late-onset epilepsy: Semiology, EEG, cerebrospinal fluid, and seizure outcome characteristics. AED, ANMS, CSF, EEG, IAMS, IANMS, ILAE, NLEOE, NLLOE
22  2019 Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen. ASO, BBB, CSF, Qalb, SMA
23  2019 The Cerebrospinal Fluid in Multiple Sclerosis. CSF, MS
24  2019 The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review. CSF, IEF, IND
25  2019 The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement. AIs, ANAs, ENA, MRZR, MS, RDwCNS
26  2018 Application of kappa free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm. CSF, KFLC, MS, ROC
27  2018 Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort. ION, ON, SNPs
28  2018 Balo's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures. BCS, CSF, LP, MS
29  2018 Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis. CSF, FLC, IgG, MS, ROC
30  2018 Evaluation of Cobas 8000 for the quantification of albumin and IgG in serum and cerebrospinal fluid. IEF, MS
31  2018 Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute? CSF, FLC, IEF, IND
32  2018 Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes. CHI3L1, NfL
33  2018 Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands. KFLC
34  2018 Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka. MS, VEP
35  2018 Prognostic Factors in Anti-Neuronal Antibody Positive Patients. ANA, GABABR, GAD, NMDAR
36  2018 Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report. MS, NMOSD
37  2018 Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS. OMS
38  2018 The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis. MS
39  2017 An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis. CSF, MS
40  2017 Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barre syndrome. CIS, CSF, EBV, GBS, MS
41  2017 Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis. CIS, CSF, MS, VEP
42  2017 Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report. CNS, CSF, INO, MS, PP, RR, SP
43  2017 Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study. CSF, OMS
44  2017 Kappa Free Light Chains in Cerebrospinal Fluid of Patients with Identified Oligoclonal Immunoglobulin G. CIS, CSF, IEF, KFLC
45  2017 Onset of secondary progressive MS after long-term rituximab therapy - a case report. CSF, RMS, SPMS
46  2017 Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Abs, ADEM, ADS, CIS, MS, NMOSD
47  2017 Prognostic value of free light chains lambda and kappa in early multiple sclerosis. CDMS, CI, CIS, CSF, FLC, HR, IQR, KFLC, MRI, MS, PBVC, T2LL
48  2017 Similar familial risk in multiple sclerosis subgroups. CSF, MS
49  2016 Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status. CSF, MS, OCBs, RR
50  2016 McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity. CSF, MS
51  2016 Molecular Approach to Targeted Therapy for Multiple Sclerosis. EBV, TGF, VEGF
52  2016 Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome. CSF, OMS
53  2015 Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis. ARR, CIS, CSF FLC, EDSS, IND, MS, NIND
54  2015 Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies. CASPR2, CNTNAP2, CSF, GTS
55  2015 Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. TDL
56  2015 Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis. MS
57  2015 Oligoclonal bands predict multiple sclerosis in children with optic neuritis. CI, HR, MS, ON
58  2015 Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients. CSF, IEF, MS, PTC
59  2015 The association between obesity and oligoclonal band formation in multiple sclerosis patients. BMI, CSF, RRMS
60  2015 The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort. ADEM, AI, AIE, MRZR, MS, NS
61  2015 The relationship between familial Mediterranean fever gene (MEFV) mutations and clinical and radiologic parameters in multiple sclerosis patients. CNS, EDSS, FMF, MEFV, MS
62  2015 Tumefactive demyelination of the spinal cord: a case report. CSF
63  2014 Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. CIS, KFLC, MS
64  2014 CSF albumin and immunoglobulin analyses in childhood neurologic disorders. Ig, QAlb
65  2014 Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production. CSF, IgG, MS, NCORE
66  2014 Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. CSF, EBV, MS, NIND, OIND, RRMS, VCA
67  2014 HHV-6-positivity in diseases with demyelination. CSF, HHV-6
68  2014 High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. CSF, FLC, MS
69  2014 Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis. CSF, Ig, PPMS
70  2014 In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. CNS, CSF, IEF, IgG, MS, PB
71  2014 Intrathecal synthesis in particular types of multiple sclerosis. CIS, CSF, EDSS, IEF, IgG, MS, RR, SP
72  2014 The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases. CSF
73  2013 Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid. MS
74  2013 Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. CL, CSF, GWAS, OR
75  2013 Clinical and pathological features of acute optic neuritis in Chinese patients. NMO, ON
76  2013 Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. ab-LE, CSF, PLE
77  2013 Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. CIS and RIS, CSF, VEP
78  2013 Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behcet's disease. BD, CSF, CVST
79  2013 Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. AAO, CSF, GWAS, MS, SNPs
80  2012 Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. AHCT, CSF, EDSS, HDIT, MS
81  2012 CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients. CSF, MS, MSSS
82  2012 Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions. EDSS, MMS, MS, VEP
83  2012 CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. MRI, MS, ON, VEP
84  2012 Diagnostic approach of patients with longitudinally extensive transverse myelitis. CSF, MS
85  2012 Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. CSF, MS
86  2012 The evidence for a role of B cells in multiple sclerosis. MS
87  2012 The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. CSF, MS
88  2012 Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG oligoclonal bands. AI, CSF
89  2011 A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination. CSF, MRI, MS
90  2011 Clinical isolated syndrome: a 3-year follow-up study in China. CDMS, CIS, CSF, NMO
91  2011 Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome. CIS, CSF, MS, RRMS
92  2011 Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. AD, CSF, FTLD, HD, MD, MND, MSA, PD, PDD, PSP, SCA, VD
93  2010 Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. MS
94  2010 The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). CIS, CSF, MRI, MRZR, MS, PPV
95  2010 [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases]. MBP, TIDD
96  2009 CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. DSS, MS
97  2009 IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. CIS, MRZR, MS, PPV
98  2009 MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns. CSF, MS
99  2009 Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of Sao Paulo. CSF, IDCNS, MS
100  2009 The discovery of oligoclonal bands: a 50-year anniversary. CSF, MS